- Home
- ATIF vs ALBT Comparison
ATIF vs ALBT Comparison
Compare ATIF & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATIF
- ALBT
- Stock Information
- Founded
- ATIF 2015
- ALBT 2014
- Country
- ATIF United States
- ALBT United States
- Employees
- ATIF N/A
- ALBT N/A
- Industry
- ATIF Professional Services
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATIF Consumer Discretionary
- ALBT Health Care
- Exchange
- ATIF Nasdaq
- ALBT Nasdaq
- Market Cap
- ATIF 9.8M
- ALBT 2.9M
- IPO Year
- ATIF 2019
- ALBT N/A
- Fundamental
- Price
- ATIF $0.86
- ALBT $0.20
- Analyst Decision
- ATIF
- ALBT
- Analyst Count
- ATIF 0
- ALBT 0
- Target Price
- ATIF N/A
- ALBT N/A
- AVG Volume (30 Days)
- ATIF 214.7K
- ALBT 633.7K
- Earning Date
- ATIF 12-13-2024
- ALBT 11-12-2024
- Dividend Yield
- ATIF N/A
- ALBT N/A
- EPS Growth
- ATIF N/A
- ALBT N/A
- EPS
- ATIF N/A
- ALBT N/A
- Revenue
- ATIF $500,000.00
- ALBT N/A
- Revenue This Year
- ATIF N/A
- ALBT N/A
- Revenue Next Year
- ATIF N/A
- ALBT N/A
- P/E Ratio
- ATIF N/A
- ALBT N/A
- Revenue Growth
- ATIF N/A
- ALBT N/A
- 52 Week Low
- ATIF $0.58
- ALBT $0.16
- 52 Week High
- ATIF $1.50
- ALBT $1.44
- Technical
- Relative Strength Index (RSI)
- ATIF 46.75
- ALBT 43.14
- Support Level
- ATIF $0.85
- ALBT $0.16
- Resistance Level
- ATIF $1.50
- ALBT $0.22
- Average True Range (ATR)
- ATIF 0.18
- ALBT 0.03
- MACD
- ATIF -0.01
- ALBT 0.00
- Stochastic Oscillator
- ATIF 15.82
- ALBT 27.54
About ATIF ATIF Holdings Limited
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.